Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC)

1.71
Delayed Data
As of 3:59pm ET
 -0.1895 / -9.98%
Today’s Change
1.50
Today|||52-Week Range
10.90
-67.67%
Year-to-Date
No recent news for Cyclacel Pharmaceuticals Inc.

Today’s Trading

Previous close1.90
Today’s open1.59
Day’s range1.58 - 1.77
Volume2,021,254
Average volume (3 months)719,858
Market cap$22.6M
Data as of 3:59pm ET, 12/12/2017

Growth & Valuation

Earnings growth (last year)+35.19%
Earnings growth (this year)+35.71%
Earnings growth (next 5 years)--
Revenue growth (last year)-56.64%
P/E ratioNM
Price/Sales21.49
Price/Book0.57

Competitors

 Today’s
change
Today’s
% change
APRIApricus Biosciences ...+0.00+0.01%
ACSTAcasti Pharma Inc-0.09-5.63%
HTBXHeat Biologics Inc+0.04+10.14%
KTOVKitov Pharmaceutical...-0.07-3.33%
Data as of 4:00pm ET, 12/12/2017

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$843.0K
Annual profit (last year)-$11.8M
Net profit margin-1,398.70%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Spiro Rombotis
COO, CFO, Secretary, Director &
Executive VP
Paul McBarron
Corporate headquarters
Berkeley Heights, New Jersey

Forecasts